Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 03/20/2026 | CALL | $62.00 | 4,000 | +4,000 | |
| 03/20/2026 | PUT | $62.00 | 4,000 | +4,000 | |
| 12/18/2026 | PUT | $55.00 | 4,429 | +2,542 | +134.71% |
| 01/15/2027 | PUT | $60.00 | 5,070 | +501 | +10.97% |
| 06/18/2026 | CALL | $62.50 | 5,299 | +478 | +9.91% |
| 03/20/2026 | CALL | $62.50 | 18,778 | +432 | +2.35% |
| 03/20/2026 | CALL | $60.00 | 26,772 | -30 | -0.11% |
| 06/18/2026 | PUT | $47.00 | 255 | -56 | -18.01% |
| 06/17/2027 | CALL | $65.00 | 186 | -78 | -29.55% |
| 06/18/2026 | CALL | $52.50 | 2,118 | -94 | -4.25% |
| 12/18/2026 | CALL | $67.50 | 1,204 | -103 | -7.88% |
| 01/15/2027 | CALL | $65.00 | 3,076 | -135 | -4.20% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.07% | 64.63M | 4.03B |
| Vanguard 500 Index Fund | 2.34% | 49.15M | 3.06B |
| Fidelity 500 Index Fund | 1.11% | 23.31M | 1.45B |
| SPDR S&P 500 ETF Trust | 1.09% | 23.02M | 1.43B |
| iShares Core S&P 500 ETF | 0.90% | 18.98M | 1.18B |
| Vanguard Index-Value Index Fund | 0.87% | 18.37M | 1.14B |
| JP Morgan Equity Income Fund | 0.82% | 17.35M | 1.08B |
| Select Sector SPDR Fund-Health Care | 0.82% | 17.27M | 1.08B |
| American Mutual Fund Inc | 0.78% | 16.49M | 1.03B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.71% | 14.9M | 927.91M |
Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030
02/25 01:54 pm
GlobeNewswire Inc.
Read moreKyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors
02/24 09:00 am
GlobeNewswire Inc.
Read moreBristol-Myers Touts Promising Data From Blood Disorder Study
02/23 02:43 pm
Benzinga
Read moreStarton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma
02/19 09:00 am
GlobeNewswire Inc.
Read moreCTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type
02/18 12:00 pm
GlobeNewswire Inc.
Read moreCheckpoint Inhibitors Competitive Landscape Report 2026: Comprehensive Insights About 50+ Companies and 60+ Drugs
02/18 11:49 am
GlobeNewswire Inc.
Read moreHepatitis B Treatment Market Size is Projected to Reach USD 7.74 Billion by 2033 Due to the Increasing Disease Management Trends Globally
02/11 05:00 am
GlobeNewswire Inc.
Read moreIdiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight
02/09 02:00 pm
GlobeNewswire Inc.
Read moreBristol Myers Flags Data-Rich 2026 After Solid Quarter
02/05 11:07 am
Benzinga
Read moreWhat's Going On With Bristol-Myers Squibb Stock Today?
02/04 02:40 pm
Benzinga
Read moreCytomX Therapeutics to Present at Upcoming February Conferences
02/04 09:00 am
GlobeNewswire Inc.
Read moreTargeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica
02/03 02:56 am
GlobeNewswire Inc.
Read moreAutologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica
01/27 02:43 pm
GlobeNewswire Inc.
Read more1 ETF Could Turn $500 Monthly Into a $800,000 Portfolio That Pays $24,000 in Annual Dividend Income
01/24 08:30 pm
The Motley Fool
Read moreJanux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million
01/22 03:02 pm
Benzinga
Read moreThe Best Stocks to Invest $1,000 in Right Now
01/21 12:45 pm
The Motley Fool
Read moreHigh Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
01/21 12:00 pm
GlobeNewswire Inc.
Read moreJohnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative
01/21 10:43 am
Investing.com
Read moreU.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships
01/21 05:52 am
GlobeNewswire Inc.
Read moreBristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool
01/20 02:02 pm
Benzinga
Read moreSystemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight
01/13 02:00 pm
GlobeNewswire Inc.
Read moreAmgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs
01/07 02:45 pm
Benzinga
Read more2 Dividend ETFs to Buy With $500 and Hold Forever
01/07 08:30 am
The Motley Fool
Read moreScenic Biotech Enters License and Research Agreement with Ono Pharmaceutical
01/07 06:00 am
GlobeNewswire Inc.
Read moreAstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial
01/06 07:43 am
Benzinga
Read more1 Top ETF I Plan to Load Up on in 2026
01/02 09:05 am
The Motley Fool
Read moreGot $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever
12/30 10:15 am
The Motley Fool
Read more3 Drug Stocks to Buy at a Discount
12/27 05:28 pm
The Motley Fool
Read moreGot $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
12/24 06:26 pm
The Motley Fool
Read moreShould Retirees Pull Their Money Out of the Stock Market in 2026?
12/21 05:30 am
The Motley Fool
Read moreImmuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - SNS Insider
12/14 09:32 am
GlobeNewswire Inc.
Read moreWant Decades of Passive Income? Buy This Index Fund and Hold It Forever.
12/14 06:15 am
The Motley Fool
Read moreBioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options
12/09 01:38 pm
Benzinga
Read moreAntibody Discovery Market to Reach USD 17.68 Billion by 2032, Driven by Rising Demand for Targeted Therapies and Advancements in AI Powered Antibody Engineering – SNS Insider
12/07 10:26 am
GlobeNewswire Inc.
Read moreDo These 3 Healthcare Stocks Need a Checkup?
12/05 05:05 pm
The Motley Fool
Read moreCAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players
12/05 06:41 am
GlobeNewswire Inc.
Read moreBristol Myers Pushes Data Readout For Key Alzheimer's Psychosis Study After Irregularities
12/03 02:51 pm
Benzinga
Read more2 Undervalued, High-Quality Companies to Buy Now and Hold Forever
11/30 10:05 pm
The Motley Fool
Read more2 Top Dividend Stocks to Buy and Hold
11/30 05:05 am
The Motley Fool
Read moreShould You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend?
11/29 07:18 am
The Motley Fool
Read moreGeriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®
11/27 11:50 pm
GlobeNewswire Inc.
Read moreBayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
11/24 02:14 pm
Benzinga
Read moreMetabolic Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 576 Deals by Company A-Z, Therapy Focus and Technology Type
11/19 11:58 am
GlobeNewswire Inc.
Read moreBristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy
11/14 12:17 pm
Benzinga
Read moreThe Market’s a Ripoff Right Now, but These 4 High Yielders Aren’t
11/14 06:37 am
Investing.com
Read morePfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
11/13 12:10 pm
Benzinga
Read moreCytomX Therapeutics to Present at the Jefferies London Healthcare Conference
11/13 09:00 am
GlobeNewswire Inc.
Read morePrime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
11/07 08:00 am
GlobeNewswire Inc.
Read more